Cancer Genomics Pioneer Honored by AMP
November 13, 2025
-
4 min
8 Key Takeaways
-
1
Dr. Elaine R. Mardis awarded the 2025 AMP Excellence Award.
-
2
Keynote focused on genomics in pediatric precision medicine.
-
3
Highlighted rapid genome sequencing in NICUs.
-
4
Emphasized collaboration in genomic research.
-
5
Discussed initiatives like the Molecular Characterization Initiative.
-
6
Advocated for data sharing and machine learning integration.
-
7
Over 550 publications authored by Dr. Mardis.
-
8
Recognized as a leader in cancer genomics and molecular diagnostics.
Elaine R. Mardis, PhD, a leader in cancer genomics, was awarded the 2025 Award for Excellence in Molecular Diagnostics by the Association for Molecular Pathology (AMP) for her significant contributions to the field. During the AMP annual meeting in Boston, she presented a keynote lecture on the impact of genomics in pediatric precision medicine, emphasizing advancements in genomic sequencing and machine learning for diagnosing rare genetic diseases. Her research at Nationwide Children’s Hospital demonstrates the transformative potential of genomics in improving patient outcomes through timely interventions.
Listen Tab content
